Bicara Therapeutics finalizes Boston headquarters sublease with Wayfair LLC
The company disclosed a 35,090-square-foot sublease at 10 St. James Avenue, with a term that could begin as soon as October 2026 and run through September 2028.
Bicara Therapeutics Inc. disclosed in an 8-K filing that on August 21, 2026, the company entered into a Sub-Sublease Agreement with Wayfair LLC, as sublandlord, to lease approximately 35,090 square feet of office space for a new corporate headquarters at 10 St. James Avenue, Boston, Massachusetts 02116.1
The lease term is set to begin on the later of (i) October 1, 2026 and (ii) the date of full execution of a consent between the Company, the Sublandlord, Liberty Mutual Insurance Company (as landlord) and MT Back Bay One LLC (as overlandlord).1
Under the agreement, base rent is $105,279 per month and will become payable nine months following the Commencement Date.1 Separately, the Company paid a security deposit totaling $210,540 in connection with entry into the Sublease.1
The sublease runs until the earlier of September 30, 2028 or the date on which the Sublease is terminated pursuant to its terms.1 The filing notes that the Sublease contains customary events of default, representations, warranties and covenants.1
The company stated that the description of the Sublease in the filing is not complete and is qualified in its entirety by reference to the full text of the Sublease, filed as Exhibit 10.1 to the Current Report.1
The Form 8-K carries a signature line dated August 25, 2026, under the name of Claire Mazumdar, Ph.D., MBA, Chief Executive Officer of Bicara Therapeutics Inc.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.